Literature DB >> 2592791

B cell hyperactivity in autoimmune continuous B cell lines.

M Aldo-Benson1, M S Brooks, L Scheiderer-Pratt.   

Abstract

Generalized increase in immunoglobulin secretion, which is a prominent feature of autoimmune diseases, may be due to abnormal T cell regulation, intrinsic abnormality of B cells, or both. To investigate this question we developed nonmalignant continuous B lymphocyte lines from 20-week-old BWF1 mice and compared their growth and immune response to that of BALB/c mice cell lines. The B cell lines contain less than 1% T cells and macrophages and require growth factors from phytohemagglutinin-stimulated EL-4 lymphoma (GF) or recombinant interleukin 4 for continuous growth. No antigens or mitogens are required for growth. In the presence of 20% GF (which is optimal for BALB/c cell growth and immune function) spontaneous growth of BWF1 B cells, and spontaneous entry into G1, was similar to that of BALB/c B cells. With concentrations of GF and anti-mu which were optimal for BALB/c, the growth and immune response of isolated BWF1 B cells are no different from those of BALB/c controls, but at suboptimal doses of GF there is a significant increase of both spontaneous immunoglobulin secretion and response to anti-mu in BWF1 B cells. Thus, these autoimmune B cells are more sensitive to the effects of both T cell factors and immunoglobulin receptors stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592791     DOI: 10.1007/bf02935512

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  19 in total

1.  Proliferation of anti-DNA-producing NZB B cells in a non-autoimmune environment.

Authors:  D M Klinman; A D Steinberg
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

2.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

Authors:  K Oliver; R J Noelle; J W Uhr; P H Krammer; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 3.  Etiopathogenesis of murine SLE.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.

Authors:  C B Thompson; I Scher; M E Schaefer; T Lindsten; F D Finkelman; J J Mond
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

5.  Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle.

Authors:  J G Monroe; J C Cambier
Journal:  J Immunol Methods       Date:  1983-09-30       Impact factor: 2.303

6.  Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect.

Authors:  K M Nies; R H Stevens; J S Louie
Journal:  Clin Immunol Immunopathol       Date:  1981-04

Review 7.  B-cell-tropic interleukins in murine systemic lupus erythematosus (SLE) 1.

Authors:  G J Prud'homme; T M Fieser; F J Dixon; A N Theofilopoulos
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

8.  Hapten-specific murine colony-forming B cells: in vitro response of colonies to fluoresceinated thymus independent antigens.

Authors:  P S Pillai; D W Scott
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

9.  2,4-Dinitrophenyl (DNP)-specific continuous B cell lines as a model system for studying B cell activation and tolerance.

Authors:  M Aldo-Benson; L Scheiderer; F E Dwulet
Journal:  Eur J Immunol       Date:  1986-01       Impact factor: 5.532

10.  Long-term growth of lines of murine dinitrophenyl-specific B lymphocytes in vitro.

Authors:  M Aldo-Benson; L Scheiderer
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.